Journal article Open Access
Leahu, Pavel;
Groppa, Stanislav
Background: Nowadays, neuro-modulation offers different devices and techniques in the treatment of neurological patients suffering from paroxysmal disorders, such as epilepsy and migraine. Among non-pharmacologic therapies, rTMS shows good results.
Material and methods: A longitudinal, double-blinded, rTMS-intervention study was conducted on 42 subjects with episodic migraine (with and without aura, 2-14 attacks per month). After a baseline follow-up for 1 month, subjects had 6 sessions of rTMS during 2 weeks and received multifocal rTMS or sham stimulation, with further 3-month assessment via questionnaires on headache frequency .
Results: After stimulation, the real rTMS group showed a reduction in the number of attacks – 7.5 ± 3.7 at baseline to 3.8 ± 2.7 attacks at 3 months’ period (p0.05). There was a significant reduction in the intensity of attacks over 4-week therapy in the treatment group (6.7 ± 1.5 at baseline; 5.3 ± 2.5 at 4 weeks (p<0.05). The conducted questionnaires revealed a positive impact on quality of life and functional outcomes. There were no serious adverse events reported.
Conclusions: Our study showed evidence that the experimental rTMS protocol significantly reduced the frequency and intensity of migraine attacks compared to placebo treatment with no serious adverse events.
Name | Size | |
---|---|---|
MMJ-2020-63-5_26-29.pdf
md5:15479a0a53780c24d4a6a145e280e5b9 |
1.6 MB | Download |
All versions | This version | |
---|---|---|
Views | 20 | 20 |
Downloads | 12 | 12 |
Data volume | 19.0 MB | 19.0 MB |
Unique views | 20 | 20 |
Unique downloads | 11 | 11 |